These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24098819)

  • 21. Reactions in leprosy: an epidemiological study of 386 patients in west Nepal.
    Van Brakel WH; Khawas IB; Lucas SB
    Lepr Rev; 1994 Sep; 65(3):190-203. PubMed ID: 8942150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial.
    de Barros B; Lambert SM; Shah M; Pai VV; Darlong J; Rozario BJ; Alinda MD; Sales AM; Doni S; Hagge DA; Shrestha D; Listiawan MY; Yitaye AM; Nery JAC; Neupane KD; Dias VLA; Butlin CR; Nicholls PG; Lockwood D; Walker SL
    BMJ Open; 2020 Nov; 10(11):e037700. PubMed ID: 33203627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Hungria EM; Oliveira RM; Penna GO; Aderaldo LC; Pontes MA; Cruz R; Gonçalves HS; Penna ML; Kerr LR; Stefani MM; Bührer-Sékula S
    Infect Dis Poverty; 2016 Dec; 5(1):110. PubMed ID: 27919284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leprosy reactions in postelimination stage: the Bangladesh experience.
    Mowla MR; Ara S; Mizanur Rahman AFM; Tripura SP; Paul S
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):705-711. PubMed ID: 27859670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
    Santaram V; Porichha D
    Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of erythema nodosum leprosum (type 2 reaction) by cytology.
    Ray R; Mondal RK; Pathak S
    Acta Cytol; 2014; 58(1):29-32. PubMed ID: 24247108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases.
    Narang T; Kaushik A; Dogra S
    Br J Dermatol; 2020 Apr; 182(4):1034-1037. PubMed ID: 31218666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
    Pal D
    Trop Doct; 2023 Oct; 53(4):533-535. PubMed ID: 37401254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell regulation in Erythema Nodosum Leprosum.
    Negera E; Walker SL; Bobosha K; Howe R; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
    Verma KK; Srivastava P; Minz A; Verma K
    Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythema nodosum leprosum on glans penis: unusual manifestation of common disease.
    Kothiwala SK; Khandpur S; Singh MK; Durgapal P
    Int J Dermatol; 2015 Sep; 54(9):1060-3. PubMed ID: 25557912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histoid leprosy: a retrospective study of 40 cases from India.
    Kaur I; Dogra S; De D; Saikia UN
    Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards understanding the pathology of erythema nodosum leprosum.
    Kahawita IP; Lockwood DN
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):329-37. PubMed ID: 18313706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.
    Gupta N; Shankernarayan NP; Dharmalingam K
    J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
    Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
    Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group specific component (Gc) in erythema nodosum leprosum (ENL).
    Ghei SK; Agrewala JN; Sengupta U; Sudhakar KS
    Indian J Lepr; 1993; 65(3):323-5. PubMed ID: 8283068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement C1q expression in Erythema nodosum leprosum.
    Negera E; Walker SL; Lema T; Aseffa A; Lockwood DN; Dockrell HM
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006321. PubMed ID: 29499046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.